Molecular-cancer.com

Countable Data Brief

Molecular-cancer.com is tracked by us since April, 2011. Over the time it has been ranked as high as 564 899 in the world, while most of its traffic comes from USA, where it reached as high as 181 772 position. It was owned by several entities, from Biomed Central Tomas Ramanauskas () to Ramanauskas Tomas of BiomedCentral, it was hosted by TeleCity Group Customer - Biomed Central Ltd, Fastly Inc. and others. While ENOM INC. was its first registrar, now it is moved to EuroDNS S.A..

Molecular-cancer has a high Google pagerank and bad results in terms of Yandex topical citation index. We found that Molecular-cancer.com is poorly ‘socialized’ in respect to any social network. According to MyWot and Google safe browsing analytics, Molecular-cancer.com is a fully trustworthy domain with no visitor reviews.

Traffic Analysis

It seems that the number of visitors and pageviews on this site is too low to be displayed, sorry.

SEO Stats

Molecular-cancer.com has Google PR 6 and its top keyword is "molecular cancer" with 13.47% of search traffic.

Social Engagement

Molecular-cancer.com has 0% of its total traffic coming from social networks (in last 3 months) and the most active engagement is detected in Facebook (624 shares)

Safety

Safety status of Molecular-cancer.com is described as follows: MyWOT reports its overall reputation as excellent and Google Safe Browsing reports its status as safe.